Guiding ATMPs to patients
Here you will find information on what is happening in Sweden in development of medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. We welcome your collaboration towards accelerated and efficacious patient solutions.
Register for ATMP Sweden 2020 in Stockholm!
Subscribe to our mailing list
Subscribe to receive our quarterly newsletter and updates on the next ATMP Sweden conference.
Follow us on LinkedIn!
Resources
Use our interactive map to find clinics, manufacture facilities and CAMP/Swelife-ATMP partners.
Use this guide to navigate development of your ATMP to Phase I!
What is the difference between a transplant and a cell based ATMP?
News
Financing ATMPs – Bedside to Reimbursement
2019-10-16
Part 2 of our September 2019 ATMP financing events in Skåne.
Read more
200 million SEK investment in Swedish gene and immunotherapy production
2019-09-23
Cobra Biologics invests 200 million SEK in Matfors facility
Read more
Swedish based Ilya Pharma recruiting for first ATMP trial
2019-09-19
Genetically engineered bacteria to drive wound healing
Read moreEvents
Work with us!
Join our experts in the science and technology for GMP compliant clinical translation of ATMPs.
Join our experts in the knowledge, processes and competencies for getting ATMPs to patients.
Help us to help you get information out about your ATMP press releases or events in Sweden!
ATMP success stories
Other collaborating national projects
VOG cell is responsible for ensuring Swedish GMP manfacturing facilities function at the highest level and are compliant with current regulations.
AdBIOPRO is developing Continuous Processing of emerging potent therapeutic products such as recombinant viral vector and cell Products.
This Group will be developing a long term strategy for the future of the ATMP field in Sweden. The Project will ensure that all necessary networks and stakeholders are involved.
See all ATMP relevant organisations here